Literature DB >> 3045551

Clinical implications of prostaglandin and thromboxane A2 formation (2).

J A Oates1, G A FitzGerald, R A Branch, E K Jackson, H R Knapp, L J Roberts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3045551     DOI： 10.1056/NEJM198809223191206

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

Review 1.  The human platelet fibrinogen receptor: clinical and therapeutic significance.

Authors:  M Cahill; R Mistry; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

2.  Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Authors:  Neil D Gross; Jay O Boyle; Jason D Morrow; Myles K Williams; Chaya S Moskowitz; Kotha Subbaramaiah; Andrew J Dannenberg; Anna J Duffield-Lillico
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

3.  Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A(2) receptor.

Authors:  Harold J Ting; Wallace J Murray; Fadi T Khasawneh
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

4.  Repeated measures of urinary oxidative stress biomarkers and preterm birth in Puerto Rico.

Authors:  Stephanie M Eick; Kelly K Ferguson; Ginger L Milne; Rafael Rios-McConnell; Carmen Vélez-Vega; Zaira Rosario; Akram Alshawabkeh; José F Cordero; John D Meeker
Journal:  Free Radic Biol Med       Date:  2019-11-05       Impact factor: 7.376

5.  Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase.

Authors:  G R Wang; Y Zhu; P V Halushka; T M Lincoln; M E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Thromboxane synthase expression and thromboxane A2 production in the atherosclerotic lesion.

Authors:  Anders Gabrielsen; Hong Qiu; Magnus Bäck; Mats Hamberg; Anne-Louise Hemdahl; Hanna Agardh; Lasse Folkersen; Jesper Swedenborg; Ulf Hedin; Gabrielle Paulsson-Berne; Jesper Z Haeggström; Göran K Hansson
Journal:  J Mol Med (Berl)       Date:  2010-04-12       Impact factor: 4.599

7.  The effect of HIV and HPV coinfection on cervical COX-2 expression and systemic prostaglandin E2 levels.

Authors:  Daniel W Fitzgerald; Karl Bezak; Oksana Ocheretina; Cynthia Riviere; Thomas C Wright; Ginger L Milne; Xi Kathy Zhou; Baoheng Du; Kotha Subbaramaiah; Erin Byrt; Matthew L Goodwin; Arash Rafii; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2011-12-01

8.  Changes in tissue polyunsaturated fatty acids with age, in spontaneously hypertensive rats.

Authors:  M C Delachambre; M Narce; P Asdrubal; J P Poisson
Journal:  Lipids       Date:  1998-08       Impact factor: 1.880

9.  Inhibition of tumor growth and metastasis by chronic intravenous infusion of prostaglandin E1.

Authors:  L M Ellis; E M Copeland; K I Bland; H S Sitren
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

10.  Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.

Authors:  G J Johnson; L A Leis; P C Dunlop
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.